Monthly Archives: February 2013

Biotech’s PR Problems Continue

Maybe “Fish gotta swim” but the FDA has extended the approval period for transgenic Salmon genetically engineered to reach market weight sooner. No evidence at all has been presented that filets from these fish would present a danger human consumers … Continue reading

Posted in Govt Policy/PTO Policy, Transgenics | Tagged , , , | Leave a comment

USPTO Publishes Extensive Examination Guidelines for 35 U.S.C. 102 and 103

On February 14, 2013, the PTO published extensive Examination Guidelines for examination of applications filed after March 16, 2013, under 102 and 103 as amended by the AIA. Given the debates, if not confusion, that arose following the publication of … Continue reading

Posted in AIA Patent Reform, USPTO Practice and Policy | Tagged , , , , | 2 Comments

High Tech Law Institute: USPTO RCE

The High Tech Law Institute of Santa Clara Law is hosting an upcoming USPTO roundtable and focus session on February 20, 2013 at 9:00. RSVP’s will be taken by the USPTO on a first come first serve basis (see following … Continue reading

Posted in Miscellaneous | Tagged , , , | Leave a comment

Time For Myriad To Fight Another Day

Put another way, it is time for Jones Day to click their well-polished heels and go home. Today, the U.S. Government filed an amicus brief largely supporting the arguments by AMP/ACLU that isolated DNA is essentially the same molecule after … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , , | 2 Comments